癌症相关疲乏的筛查与评估:面向医疗服务提供者的临床实践指南
癌症相关疲乏是癌症治疗最常见的不良反应,建议定期监测,但少有指南透明评估研究偏倚、质量和临床效用。本临床实践指南遵循AGREE声明和ECRI指南信托评分卡,系统检索文献、评估证据质量并纳入多学科利益相关者意见,审查了114篇文章支持的10种筛查工具和15种评估工具。1种筛查工具(EORTC QLQ-C30核心问卷)和3种评估工具(Piper疲乏量表修订版、FACIT-F疲乏量表、PROMIS疲乏简表)获得A级推荐(“应在临床实践中使用”),1种筛查工具和5种评估工具获得B级推荐(“可在临床实践中使用”)。医疗服务提供者应在连续照护中选用推荐工具筛查和评估癌症相关疲乏,并需更多研究评估这些工具的反应度以用作结局指标。
要点
- 推荐使用EORTC QLQ-C30核心问卷筛查癌症相关疲乏(A级推荐,“应在临床实践中使用”)。
- 推荐使用Piper疲乏量表修订版、FACIT-F疲乏量表或PROMIS疲乏简表评估癌症相关疲乏(A级推荐,“应在临床实践中使用”)。
- 另有1种筛查工具和5种评估工具获得B级推荐(“可在临床实践中使用”)。
- 本指南基于AGREE声明和ECRI指南信托评分卡制定,系统检索并评估了114篇文章支持的10种筛查工具和15种评估工具。
- 需要更多研究评估这些工具的反应度,以便将其用作结局指标。
适用人群与场景
- 接受癌症治疗的个体。
处置流程与药物剂量
- 医疗服务提供者应使用本指南推荐的工具之一筛查和评估癌症相关疲乏。
- 筛查可使用EORTC QLQ-C30核心问卷(A级推荐,“应在临床实践中使用”)。
- 评估可使用Piper疲乏量表修订版、FACIT-F疲乏量表或PROMIS疲乏简表(A级推荐,“应在临床实践中使用”)。
研究设计与关键结果
- 本指南遵循AGREE声明和ECRI指南信托评分卡制定,包括系统文献检索、证据质量评估和多学科利益相关者意见。
- 审查了114篇文章支持的10种筛查工具和15种评估工具。
- 1种筛查工具(EORTC QLQ-C30核心问卷)和3种评估工具(Piper疲乏量表修订版、FACIT-F疲乏量表、PROMIS疲乏简表)获得A级推荐(“应在临床实践中使用”)。
- 1种筛查工具和5种评估工具获得B级推荐(“可在临床实践中使用”)。
- 大量可用工具可能导致研究证据不全面,使测量工具的证据体系存在空白。
- 需要更多研究评估这些工具的反应度,以便将其用作结局指标。
证据类型、等级与局限
- 证据类型:临床实践指南。
- 证据等级:A级推荐(“应在临床实践中使用”)和B级推荐(“可在临床实践中使用”)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 医疗服务提供者应在连续照护中选用本指南推荐的筛查和评估工具来筛查和评估癌症相关疲乏。
- 医疗服务提供者在选择筛查和评估工具时有多种选择。
指南或共识出处
- 指南名称:癌症相关疲乏的筛查与评估:面向医疗服务提供者的临床实践指南(Screening and Assessment of Cancer-Related Fatigue: A Clinical Practice Guideline for Health Care Providers)。
- 发布机构:原文未明确列出机构名称,期刊为Phys Ther。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Cancer-related fatigue (CRF) is the most common side effect of cancer treatment. Regular surveillance is recommended, but few clinical practice guidelines transparently assess study bias, quality, and clinical utility in deriving recommendations of screening and assessment methods. The purpose of this clinical practice guideline (CPG) is to provide recommendations for the screening and assessment of CRF for health care professions treating individuals with cancer. Following best practices for development of a CPG using the Appraisal of Guidelines for Research and Evaluation (AGREE) Statement and Emergency Care Research Institute (ECRI) Guidelines Trust Scorecard, this CPG included a systematic search of the literature, quality assessment of included evidence, and stakeholder input from diverse health care fields to derive the final CPG. Ten screening and 15 assessment tools supported by 114 articles were reviewed. One screen (European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire-30 Core Questionnaire) and 3 assessments (Piper Fatigue Scale-Revised, Functional Assessment of Chronic Illness Therapy-Fatigue, and Patient Reported Outcome Measurement Information System [PROMIS] Fatigue-SF) received an A recommendation ("should be used in clinical practice"), and 1 screen and 5 assessments received a B recommendation ("may be used in clinical practice"). Health care providers have choice in determining appropriate screening and assessment tools to be used across the survivorship care continuum. The large number of tools available to screen for or assess CRF may result in a lack of comprehensive research evidence, leaving gaps in the body of evidence for measurement tools. More research into the responsiveness of these tools is needed in order to adopt their use as outcome measures.
IMPACT: Health care providers should screen for and assess CRF using one of the tools recommended by this CPG.
参考来源
- Fisher MI, Cohn JC, Harrington SE, et al. Screening and Assessment of Cancer-Related Fatigue: A Clinical Practice Guideline for Health Care Providers. Phys Ther. 2022. PMID: 36179114. doi:10.1093/ptj/pzac120
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。